Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Donegan Insider Profile

11 Followers

Michael Donegan, Prin. Fin. and Acctg. Officer at TherapeuticsMD, holds 61.85K shares in TherapeuticsMD (Ticker: TXMD).

Michael Donegan's Trading History

TXMD
TherapeuticsMD
Apr 14, 2023Prin. Fin. and Acctg. OfficerUninformative Buy181.50K$115.67K
TXMD
Insider Shares: 61.85K (0.62%)

Michael Donegan has not reported any informative transactions for TXMD, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 14, 2023Uninformative Buy$181.50K50,000$3.63―
Jan 30, 2023Uninformative Buy$21.51K4,243$5.06―
Jan 25, 2023Uninformative Buy$16.29K3,056$5.32―
Dec 09, 2022Uninformative Buy$12.24K2,566$4.77―
Dec 02, 2021Uninformative Buy$45.16K85,210$0.53―

You May Also Like

Michael Donegan insider profile FAQ

What stocks does Michael Donegan hold?
Michael Donegan holds: TXMD stocks.
What was Michael Donegan’s latest transaction?
Michael Donegan’s latest transaction was an Uninformative Buy of $181.50K.
What is Michael Donegan's role in TherapeuticsMD?
Michael Donegan's role in TherapeuticsMD is Prin. Fin. and Acctg. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.